Your session is about to expire
← Back to Search
Noninvasive Brain Stimulation
Transcranial Magnetic Stimulation for Cognitive Function
N/A
Recruiting
Led By Derek E Nee, PhD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, pre-intervention and immediately after intervention
Awards & highlights
Summary
This trial looks at how a non-invasive brain stimulation called TMS affects brain regions linked to focus and attention.
Who is the study for?
This trial is for right-handed individuals aged 18-30 who speak English fluently, having learned it by age 6. It's not suitable for those with neurological or psychiatric disorders, pregnant women, people with tinnitus, a family history of epilepsy, or anyone taking pro-epileptic drugs or medications.Check my eligibility
What is being tested?
The study is testing the effects of transcranial magnetic stimulation (TMS) on two brain areas: the prefrontal cortex and posterior parietal cortex. TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain.See study design
What are the potential side effects?
Potential side effects of TMS may include discomfort at the site of stimulation, headache, lightheadedness, tingling sensations on the scalp or face during treatment. Serious side effects are rare but can include seizures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, pre-intervention and immediately after intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, pre-intervention and immediately after intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in PFC-PPC activation
Change in PFC-PPC effective connectivity
Secondary outcome measures
Change in contextual control accuracy
Change in contextual control speed
Change in temporal control accuracy
+1 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: MFG-TMSExperimental Treatment1 Intervention
Transcranial magnetic stimulation to the middle frontal gyrus. 600 pulses delivered in 50 Hz bursts every 5 Hz for 2 seconds repeated every 10 seconds at 80% of active motor threshold.
Group II: FPl-TMSExperimental Treatment1 Intervention
Transcranial magnetic stimulation to the lateral frontal pole. 600 pulses delivered in 50 Hz bursts every 5 Hz for 2 seconds repeated every 10 seconds at 80% of active motor threshold.
Group III: S1-TMSActive Control1 Intervention
Transcranial magnetic stimulation to the primary somatosensory cortex. 600 pulses delivered in 50 Hz bursts every 5 Hz for 2 seconds repeated every 10 seconds at 80% of active motor threshold.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
transcranial magnetic stimulation
2013
Completed Phase 2
~710
Find a Location
Who is running the clinical trial?
Florida State UniversityLead Sponsor
204 Previous Clinical Trials
32,322 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,820 Previous Clinical Trials
2,692,779 Total Patients Enrolled
Derek E Nee, PhDPrincipal InvestigatorFlorida State University
1 Previous Clinical Trials
50 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of neurological disorders.I am taking medication for a mental health or neurological condition.My family has a history of epilepsy.I have been fluent in English since I was 6 years old.I am not taking any medications that can cause seizures.I experience ringing in my ears.I am between 18 and 30 years old.
Research Study Groups:
This trial has the following groups:- Group 1: FPl-TMS
- Group 2: MFG-TMS
- Group 3: S1-TMS
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger